Stocks
Kura Oncology, Inc.KURA
NASDAQHealthcareBiotechnology$8.65-2.15%
A clinical-stage biotechnology company focused on developing targeted therapies for cancer, with a pipeline centered on precision medicines for genetically defined tumors. The San Diego–based firm’s lead programs include menin inhibitors for acute leukemias and other oncology candidates advancing th...
Market Cap: $764.1M52W Range: $5.41 – $12.49
Congressional Interest in Kura Oncology, Inc. (KURA)
1 member of Congress has disclosed 1 trade in Kura Oncology, Inc. (KURA), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading KURA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | buy | $1K – $15K |